Malinin NL, Boldin MP, Kovalenko AV, Wallach D (1997). „MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1”. Nature. 385 (6616): 540—4. PMID9020361. doi:10.1038/385540a0.
Luftig, M A; Cahir-McFarland E; et al. (2001). „Effects of the NIK aly mutation on NF-kappaB activation by the Epstein-Barr virus latent infection membrane protein, lymphotoxin beta receptor, and CD40”. J. Biol. Chem. United States. 276 (18): 14602—6. ISSN0021-9258. PMID11278268. doi:10.1074/jbc.C100103200.
Malinin, N L; Boldin M P; et al. (1997). „MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1”. Nature. ENGLAND. 385 (6616): 540—4. ISSN0028-0836. PMID9020361. doi:10.1038/385540a0.
Xiao, G; Sun S C (2000). „Negative regulation of the nuclear factor kappa B-inducing kinase by a cis-acting domain”. J. Biol. Chem. UNITED STATES. 275 (28): 21081—5. ISSN0021-9258. PMID10887201. doi:10.1074/jbc.M002552200.
Ninomiya-Tsuji, J; Kishimoto K; et al. (1999). „The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway”. Nature. ENGLAND. 398 (6724): 252—6. ISSN0028-0836. PMID10094049. doi:10.1038/18465.
nih.gov
ncbi.nlm.nih.gov
Malinin NL, Boldin MP, Kovalenko AV, Wallach D (1997). „MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1”. Nature. 385 (6616): 540—4. PMID9020361. doi:10.1038/385540a0.
Luftig, M A; Cahir-McFarland E; et al. (2001). „Effects of the NIK aly mutation on NF-kappaB activation by the Epstein-Barr virus latent infection membrane protein, lymphotoxin beta receptor, and CD40”. J. Biol. Chem. United States. 276 (18): 14602—6. ISSN0021-9258. PMID11278268. doi:10.1074/jbc.C100103200.
Malinin, N L; Boldin M P; et al. (1997). „MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1”. Nature. ENGLAND. 385 (6616): 540—4. ISSN0028-0836. PMID9020361. doi:10.1038/385540a0.
Xiao, G; Sun S C (2000). „Negative regulation of the nuclear factor kappa B-inducing kinase by a cis-acting domain”. J. Biol. Chem. UNITED STATES. 275 (28): 21081—5. ISSN0021-9258. PMID10887201. doi:10.1074/jbc.M002552200.
Ninomiya-Tsuji, J; Kishimoto K; et al. (1999). „The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway”. Nature. ENGLAND. 398 (6724): 252—6. ISSN0028-0836. PMID10094049. doi:10.1038/18465.
worldcat.org
Luftig, M A; Cahir-McFarland E; et al. (2001). „Effects of the NIK aly mutation on NF-kappaB activation by the Epstein-Barr virus latent infection membrane protein, lymphotoxin beta receptor, and CD40”. J. Biol. Chem. United States. 276 (18): 14602—6. ISSN0021-9258. PMID11278268. doi:10.1074/jbc.C100103200.
Malinin, N L; Boldin M P; et al. (1997). „MAP3K-related kinase involved in NF-kappaB induction by TNF, CD95 and IL-1”. Nature. ENGLAND. 385 (6616): 540—4. ISSN0028-0836. PMID9020361. doi:10.1038/385540a0.
Xiao, G; Sun S C (2000). „Negative regulation of the nuclear factor kappa B-inducing kinase by a cis-acting domain”. J. Biol. Chem. UNITED STATES. 275 (28): 21081—5. ISSN0021-9258. PMID10887201. doi:10.1074/jbc.M002552200.
Ninomiya-Tsuji, J; Kishimoto K; et al. (1999). „The kinase TAK1 can activate the NIK-I kappaB as well as the MAP kinase cascade in the IL-1 signalling pathway”. Nature. ENGLAND. 398 (6724): 252—6. ISSN0028-0836. PMID10094049. doi:10.1038/18465.